Comparison of minor bleeding complications using dabigatran or enoxaparin after cemented total hip arthroplasty
BACKGROUND: Orally administered chemical thromboprophylactic agents for total hip replacement (THR) have become popular in recent years. Certain clinical trials suggest that the efficacy and the risk of major bleeding after administration of direct thrombin inhibitor dabigatran etexilate are equiva...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2014
|
| Sorozat: | ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
134 No. 4 |
| doi: | 10.1007/s00402-014-1933-8 |
| mtmt: | 2790842 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/11358 |